Literature DB >> 20541337

Incidence of long-term ipsilateral and contralateral ototoxicity following radiotherapy for nasopharyngeal carcinoma.

Hiroyuki Wakisaka1, Hiroyuki Yamada, Kazumi Motoyoshi, Toru Ugumori, Hirotaka Takahashi, Masamitsu Hyodo.   

Abstract

OBJECTIVE: To characterize the long-term adverse effects of radiotherapy on the ears in patients with nasopharyngeal carcinoma (NPC), we investigated ipsilateral and contralateral ototoxicities in the external, middle, and inner ear.
METHODS: The records of 48 ears in 24 radiotherapy-treated NPC patients were retrospectively analyzed. Radiotherapy doses varied between 60 and 70 Gy in 2-Gy fractions at 5 fractions/week. Ototoxicities were identified by otoscope and pure-tone audiograms conducted at 2-3 month intervals for ≥12 months. The relationship between radiation dosage and sensorineural threshold deterioration was statistically compared using the Mann-Whitney U-test.
RESULTS: Post-radiotherapy, 50% of all ears (3 of 6) that developed severe otitis externa were on the contralateral side. There was a post-radiotherapy increase in contralateral otitis media with effusion (OME) (1-7 ears), but a decrease in ipsilateral cases (16-12 ears), with 2 ears on either side subsequently developing chronic otitis media (COM). All ears that showed sensorineural hearing loss (SNHL) before radiotherapy exhibited a further threshold deterioration of more than 15 dB. No statistically significant difference (p=0.086) in average radiation dose was seen between ears with sensorineural threshold deterioration (50.0 Gy) and those without (48.2 Gy).
CONCLUSION: Long-term ototoxicity following radiotherapy for NPC can occur in either the ipsilateral or contralateral ears. Pathophysiology varies between and within each side. The post-therapy increase in OME on the contralateral side was thought to be due to radiotherapy-induced Eustachian tube damage, and the sensorineural threshold deterioration in at least 4 ears was thought to be due to chronic cochlea damage secondary to COM. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20541337     DOI: 10.1016/j.anl.2010.03.012

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  6 in total

1.  SmartArc-based volumetric modulated arc therapy can improve the middle ear, vestibule and cochlea sparing for locoregionally advanced nasopharyngeal carcinoma: a dosimetric comparison with step-and-shoot intensity-modulated radiotherapy.

Authors:  J Gao; T-L Qian; C-Z Tao; Y-H Zhang; Y Zhou; J Yang; J He; R Wang; P-J Zhou
Journal:  Br J Radiol       Date:  2015-06-25       Impact factor: 3.039

2.  Is intensity-modulated radiotherapy superior to conventional techniques to prevent late ear complications of nasopharyngeal cancer?

Authors:  Ayca Ant; Ömer Yazici; Pinar Atabey; Ferit Ferhat Aslan; Arzubetul Duran; Samet Ozlugedik; Yusuf Kemal Kemaloglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-22       Impact factor: 2.503

3.  Comparison of acute toxicities in two primary chemoradiation regimens in the treatment of advanced head and neck squamous cell carcinoma.

Authors:  Katherine Y Fan; Hrishikesh Gogineni; David Zaboli; Spencer Lake; Marianna L Zahurak; Simon R Best; Marshall A Levine; Mei Tang; Eva S Zinreich; John R Saunders; Joseph A Califano; Ray G Blanco; Sara I Pai; Barbara Messing; Patrick K Ha
Journal:  Ann Surg Oncol       Date:  2012-06       Impact factor: 5.344

4.  The effectiveness of myringotomy and ventilation tube insertion versus observation in post-radiation otitis media with effusion.

Authors:  Paninee Charusripan; Likhit Khattiyawittayakun
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-24       Impact factor: 2.503

5.  Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques.

Authors:  Chung-Feng Hwang; Fu-Min Fang; Ming-Ying Zhuo; Chao-Hui Yang; Li-Na Yang; Hui-Shan Hsieh
Journal:  Biomed Res Int       Date:  2015-08-16       Impact factor: 3.411

Review 6.  Head and neck cancer survivorship consensus statement from the American Head and Neck Society.

Authors:  Neerav Goyal; Andrew Day; Joel Epstein; Joseph Goodman; Evan Graboyes; Scharukh Jalisi; Ana P Kiess; Jamie A Ku; Matthew C Miller; Aru Panwar; Vijay A Patel; Assuntina Sacco; Vlad Sandulache; Amy M Williams; Daniel Deschler; D Gregory Farwell; Cherie-Ann Nathan; Carole Fakhry; Nishant Agrawal
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.